ReP USP - Resultado da busca

Artigo de periodico
Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis (2024)
Zúñiga, Gerardo Andrés Libreros ; Pavão, Danilo Pavão e ; Barroso, Vinícius de Morais ; Mesquita, Nathalya Cristina de Moraes Roso; Braga, Saulo Fehelberg Pinto; Oliva, Glaucius ; Ferreira, Rafaela Salgado ; Ishida, Kelly ; Dias, Marcio Vinicius Bertacine
Source: Bioorganic Chemistry. Unidades: IFSC, ICB
Subjects: QUÍMICA MÉDICA, TUBERCULOSE, PLANEJAMENTO DE FÁRMACOS, MYCOBACTERIUM TUBERCULOSIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZÚÑIGA, Gerardo Andrés Libreros et al. Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis. Bioorganic Chemistry, v. 142, n. Ja 2024, p. 106960-1-106960-11, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2023.106960. Acesso em: 29 jun. 2024.
APA
Zúñiga, G. A. L., Pavão, D. P. e, Barroso, V. de M., Mesquita, N. C. de M. R., Braga, S. F. P., Oliva, G., et al. (2024). Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis. Bioorganic Chemistry, 142( Ja 2024), 106960-1-106960-11. doi:10.1016/j.bioorg.2023.106960
NLM
Zúñiga GAL, Pavão DP e, Barroso V de M, Mesquita NC de MR, Braga SFP, Oliva G, Ferreira RS, Ishida K, Dias MVB. Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis [Internet]. Bioorganic Chemistry. 2024 ; 142( Ja 2024): 106960-1-106960-11.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.bioorg.2023.106960
Vancouver
Zúñiga GAL, Pavão DP e, Barroso V de M, Mesquita NC de MR, Braga SFP, Oliva G, Ferreira RS, Ishida K, Dias MVB. Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis [Internet]. Bioorganic Chemistry. 2024 ; 142( Ja 2024): 106960-1-106960-11.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.bioorg.2023.106960
Artigo de periodico
Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein (2023)
Bitencourt, Natália Vitória ; Righetto, Gabriela Marinho; Camargo, Ilana Lopes Baratella da Cunha ; Godoy, Mariana Ortiz de ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Santos Filho, Norival Alves ; Cilli, Eduardo Maffud
Source: Pharmaceutics. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITENCOURT, Natália Vitória et al. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, v. 15, n. 2, p. 436-1-436-17 + supplementary materials: 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15020436. Acesso em: 29 jun. 2024.
APA
Bitencourt, N. V., Righetto, G. M., Camargo, I. L. B. da C., Godoy, M. O. de, Guido, R. V. C., Oliva, G., et al. (2023). Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, 15( 2), 436-1-436-17 + supplementary materials: 1-8. doi:10.3390/pharmaceutics15020436
NLM
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Vancouver
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Artigo de periodico
An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition (2023)
Noske, Gabriela Dias; Song, Yun; Fernandes, Rafaela Sachetto ; Chalk, Rod; Elmassoudi, Haitem; Koekemoer, Lizbé; Owen, Christopher David ; El-Baba, Tarick John; Robinson, Dame Carol ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Source: Nature Communications. Unidade: IFSC
Subjects: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition. Nature Communications, v. 14, p. 1545-1-1545-13 + supplementary information, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41467-023-37035-5. Acesso em: 29 jun. 2024.
APA
Noske, G. D., Song, Y., Fernandes, R. S., Chalk, R., Elmassoudi, H., Koekemoer, L., et al. (2023). An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition. Nature Communications, 14, 1545-1-1545-13 + supplementary information. doi:10.1038/s41467-023-37035-5
NLM
Noske GD, Song Y, Fernandes RS, Chalk R, Elmassoudi H, Koekemoer L, Owen CD, El-Baba TJ, Robinson DC, Oliva G, Godoy AS de. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition [Internet]. Nature Communications. 2023 ; 14 1545-1-1545-13 + supplementary information.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/s41467-023-37035-5
Vancouver
Noske GD, Song Y, Fernandes RS, Chalk R, Elmassoudi H, Koekemoer L, Owen CD, El-Baba TJ, Robinson DC, Oliva G, Godoy AS de. An in-solution snapshot of SARS-COV-2main protease maturation process and inhibition [Internet]. Nature Communications. 2023 ; 14 1545-1-1545-13 + supplementary information.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/s41467-023-37035-5
Trabalho de evento-resumo
Synthesis of oxadiazole and hydantoin derivatives as potential zika virus NS3 helicase inhibitors (2023)
Bernardes, Ana Claudia Bergler; Vidal, Hérika Danielle Almeida; Morão, Luana Galvão ; Mesquita, Nathalya Cristina de Moraes Roso; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Corrêa, Arlene Gonçalves
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidade: IFSC
Subjects: ZIKA VÍRUS, QUÍMICA ORGÂNICA, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERNARDES, Ana Claudia Bergler et al. Synthesis of oxadiazole and hydantoin derivatives as potential zika virus NS3 helicase inhibitors. 2023, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2023. Disponível em: https://www.eventweb.com.br/46rasbq/specific-files/manuscripts/46rasbq/333_1675909121.pdf. Acesso em: 29 jun. 2024.
APA
Bernardes, A. C. B., Vidal, H. D. A., Morão, L. G., Mesquita, N. C. de M. R., Guido, R. V. C., Oliva, G., & Corrêa, A. G. (2023). Synthesis of oxadiazole and hydantoin derivatives as potential zika virus NS3 helicase inhibitors. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/46rasbq/specific-files/manuscripts/46rasbq/333_1675909121.pdf
NLM
Bernardes ACB, Vidal HDA, Morão LG, Mesquita NC de MR, Guido RVC, Oliva G, Corrêa AG. Synthesis of oxadiazole and hydantoin derivatives as potential zika virus NS3 helicase inhibitors [Internet]. Anais. 2023 ;[citado 2024 jun. 29 ] Available from: https://www.eventweb.com.br/46rasbq/specific-files/manuscripts/46rasbq/333_1675909121.pdf
Vancouver
Bernardes ACB, Vidal HDA, Morão LG, Mesquita NC de MR, Guido RVC, Oliva G, Corrêa AG. Synthesis of oxadiazole and hydantoin derivatives as potential zika virus NS3 helicase inhibitors [Internet]. Anais. 2023 ;[citado 2024 jun. 29 ] Available from: https://www.eventweb.com.br/46rasbq/specific-files/manuscripts/46rasbq/333_1675909121.pdf
Artigo de periodico
Copper-catalyzed synthesis of pyrrolo[1,2-c]quinazolines and pyrrolo[2,1-a]isoquinolines and antiplasmodial evaluation (2023)
Moreira, Natália Menezes; Miranda, Ingrid Telles de; Santos, Jhonathan Renner Nunes dos ; Opatz, Till ; Oliva, Glaucius ; Guido, Rafael Victorio Carvalho ; Corrêa, Arlene Gonçalves
Source: Journal of Organic Chemistry. Unidade: IFSC
Subjects: COBRE, CATALISADORES, COMPOSTOS ORGÂNICOS, SOLVENTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Natália Menezes et al. Copper-catalyzed synthesis of pyrrolo[1,2-c]quinazolines and pyrrolo[2,1-a]isoquinolines and antiplasmodial evaluation. Journal of Organic Chemistry, v. 88, n. 13, p. 8781-8790 + supporting information: 1-30, 2023Tradução . . Disponível em: https://doi.org/10.1021/acs.joc.3c00616. Acesso em: 29 jun. 2024.
APA
Moreira, N. M., Miranda, I. T. de, Santos, J. R. N. dos, Opatz, T., Oliva, G., Guido, R. V. C., & Corrêa, A. G. (2023). Copper-catalyzed synthesis of pyrrolo[1,2-c]quinazolines and pyrrolo[2,1-a]isoquinolines and antiplasmodial evaluation. Journal of Organic Chemistry, 88( 13), 8781-8790 + supporting information: 1-30. doi:10.1021/acs.joc.3c00616
NLM
Moreira NM, Miranda IT de, Santos JRN dos, Opatz T, Oliva G, Guido RVC, Corrêa AG. Copper-catalyzed synthesis of pyrrolo[1,2-c]quinazolines and pyrrolo[2,1-a]isoquinolines and antiplasmodial evaluation [Internet]. Journal of Organic Chemistry. 2023 ; 88( 13): 8781-8790 + supporting information: 1-30.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acs.joc.3c00616
Vancouver
Moreira NM, Miranda IT de, Santos JRN dos, Opatz T, Oliva G, Guido RVC, Corrêa AG. Copper-catalyzed synthesis of pyrrolo[1,2-c]quinazolines and pyrrolo[2,1-a]isoquinolines and antiplasmodial evaluation [Internet]. Journal of Organic Chemistry. 2023 ; 88( 13): 8781-8790 + supporting information: 1-30.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acs.joc.3c00616
Artigo de periodico
Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 (2023)
Puhl, Ana Cristina ; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Nakamura, Aline Minali; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto ; Oliva, Glaucius ; Ekins, Sean
Source: ACS Omega. Unidade: IFSC
Subjects: COVID-19, PEPTÍDEOS, AGENTES ANTIMICROBIANOS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana Cristina et al. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, v. 8, n. 25, p. 22603-22612, 2023Tradução . . Disponível em: https://doi.org/10.1021/acsomega.3c01110. Acesso em: 29 jun. 2024.
APA
Puhl, A. C., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., Gawriljuk, V. O., Fernandes, R. S., et al. (2023). Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2. ACS Omega, 8( 25), 22603-22612. doi:10.1021/acsomega.3c01110
NLM
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acsomega.3c01110
Vancouver
Puhl AC, Godoy AS de, Noske GD, Nakamura AM, Gawriljuk VO, Fernandes RS, Oliva G, Ekins S. Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2 [Internet]. ACS Omega. 2023 ; 8( 25): 22603-22612.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acsomega.3c01110
Artigo de periodico
Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4 (2023)
Martins, Daniel Oliveira Silva; Souza, Rafael Aparecido Carvalho; Freire, Marjorie Caroline Liberato Cavalcanti ; Mesquita, Nathalya Cristina de Moraes Roso; Santos, Igor de Andrade ; Oliveira, Débora Moraes de; Nicolau Junior, Nilson; Paiva, Raphael Enoque Ferraz de; Harris, Mark; Oliveira, Carolina Gonçalves; Oliva, Glaucius ; Jardim, Ana Carolina Gomes
Source: Journal of Biological Inorganic Chemistry. Unidade: IFSC
Subjects: VÍRUS CHIKUNGUNYA, ANTIVIRAIS, MECANISMOS DE DEFESA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Daniel Oliveira Silva et al. Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4. Journal of Biological Inorganic Chemistry, v. 28, n. 2, p. 101-115 + supplementary information, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00775-022-01974-z. Acesso em: 29 jun. 2024.
APA
Martins, D. O. S., Souza, R. A. C., Freire, M. C. L. C., Mesquita, N. C. de M. R., Santos, I. de A., Oliveira, D. M. de, et al. (2023). Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4. Journal of Biological Inorganic Chemistry, 28( 2), 101-115 + supplementary information. doi:10.1007/s00775-022-01974-z
NLM
Martins DOS, Souza RAC, Freire MCLC, Mesquita NC de MR, Santos I de A, Oliveira DM de, Nicolau Junior N, Paiva REF de, Harris M, Oliveira CG, Oliva G, Jardim ACG. Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4 [Internet]. Journal of Biological Inorganic Chemistry. 2023 ; 28( 2): 101-115 + supplementary information.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s00775-022-01974-z
Vancouver
Martins DOS, Souza RAC, Freire MCLC, Mesquita NC de MR, Santos I de A, Oliveira DM de, Nicolau Junior N, Paiva REF de, Harris M, Oliveira CG, Oliva G, Jardim ACG. Insights into the role of the cobalt(III)-thiosemicarbazone complex as a potential inhibitor of the Chikungunya virus nsP4 [Internet]. Journal of Biological Inorganic Chemistry. 2023 ; 28( 2): 101-115 + supplementary information.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1007/s00775-022-01974-z
Artigo de periodico
Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease (2023)
Noske, Gabriela Dias; Silva, Ellen de Souza; Godoy, Mariana Ortiz de ; Dolci, Isabela ; Fernandes, Rafaela Sachetto ; Guido, Rafael Victorio Carvalho ; Sjo, Peter ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Source: Journal of Biological Chemistry. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, RESISTÊNCIA MICROBIANA ÀS DROGAS, MUTAÇÃO GENÉTICA, RAIOS X, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOSKE, Gabriela Dias et al. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. Journal of Biological Chemistry, v. 299, n. 3, p. 103004-1-103004-10 + supporting information: 1-3, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.jbc.2023.103004. Acesso em: 29 jun. 2024.
APA
Noske, G. D., Silva, E. de S., Godoy, M. O. de, Dolci, I., Fernandes, R. S., Guido, R. V. C., et al. (2023). Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease. Journal of Biological Chemistry, 299( 3), 103004-1-103004-10 + supporting information: 1-3. doi:10.1016/j.jbc.2023.103004
NLM
Noske GD, Silva E de S, Godoy MO de, Dolci I, Fernandes RS, Guido RVC, Sjo P, Oliva G, Godoy AS de. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease [Internet]. Journal of Biological Chemistry. 2023 ; 299( 3): 103004-1-103004-10 + supporting information: 1-3.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.jbc.2023.103004
Vancouver
Noske GD, Silva E de S, Godoy MO de, Dolci I, Fernandes RS, Guido RVC, Sjo P, Oliva G, Godoy AS de. Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease [Internet]. Journal of Biological Chemistry. 2023 ; 299( 3): 103004-1-103004-10 + supporting information: 1-3.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.jbc.2023.103004
Artigo de periodico
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors (2023)
Boby, Melissa L.; Fernandes, Rafaela Sachetto ; Gawriljuk, Victor Oliveira; Godoy, Andre Schutzer de ; Nakamura, Aline Minali; Noske, Gabriela Dias; Oliva, Glaucius ; Rangel, Victor Lopes
Source: Science. Unidades: IFSC, FCFRP
Subjects: COVID-19, ENZIMAS, ESPECTROSCOPIA, PROTEÍNAS, PLANEJAMENTO DE FÁRMACOS, MICROSCOPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOBY, Melissa L. et al. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, v. 382, n. 6671, p. eabo7201-1-eabo7201-16 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1126/science.abo7201. Acesso em: 29 jun. 2024.
APA
Boby, M. L., Fernandes, R. S., Gawriljuk, V. O., Godoy, A. S. de, Nakamura, A. M., Noske, G. D., et al. (2023). Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science, 382( 6671), eabo7201-1-eabo7201-16 + supplementary materials. doi:10.1126/science.abo7201
NLM
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1126/science.abo7201
Vancouver
Boby ML, Fernandes RS, Gawriljuk VO, Godoy AS de, Nakamura AM, Noske GD, Oliva G, Rangel VL. Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors [Internet]. Science. 2023 ; 382( 6671): eabo7201-1-eabo7201-16 + supplementary materials.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1126/science.abo7201
Trabalho de evento-resumo
Discovery of RNA-dependent RNA polymerase complex (RDRP) inhibitors from SARS-COV-2 as hits for COVID-19 drug development (2023)
Godoy, Mariana Ortiz de ; Oliveira, Juliana Roberta Torini de Souza; Oliva, Glaucius ; Guido, Rafael Victorio Carvalho
Source: Anais eletrônicos. Conference titles: Annual Meeting of the Brazilian Biophysical Society - SBBf. Unidade: IFSC
Subjects: COVID-19, CORONAVIRUS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Mariana Ortiz de et al. Discovery of RNA-dependent RNA polymerase complex (RDRP) inhibitors from SARS-COV-2 as hits for COVID-19 drug development. 2023, Anais.. Campinas: Galoá, 2023. Disponível em: https://proceedings.science/sbbf-2023/papers/discovery-of-rna-dependent-rna-polymerase-complex-rdrp-inhibitors-from-sars-cov?lang=en. Acesso em: 29 jun. 2024.
APA
Godoy, M. O. de, Oliveira, J. R. T. de S., Oliva, G., & Guido, R. V. C. (2023). Discovery of RNA-dependent RNA polymerase complex (RDRP) inhibitors from SARS-COV-2 as hits for COVID-19 drug development. In Anais eletrônicos. Campinas: Galoá. Recuperado de https://proceedings.science/sbbf-2023/papers/discovery-of-rna-dependent-rna-polymerase-complex-rdrp-inhibitors-from-sars-cov?lang=en
NLM
Godoy MO de, Oliveira JRT de S, Oliva G, Guido RVC. Discovery of RNA-dependent RNA polymerase complex (RDRP) inhibitors from SARS-COV-2 as hits for COVID-19 drug development [Internet]. Anais eletrônicos. 2023 ;[citado 2024 jun. 29 ] Available from: https://proceedings.science/sbbf-2023/papers/discovery-of-rna-dependent-rna-polymerase-complex-rdrp-inhibitors-from-sars-cov?lang=en
Vancouver
Godoy MO de, Oliveira JRT de S, Oliva G, Guido RVC. Discovery of RNA-dependent RNA polymerase complex (RDRP) inhibitors from SARS-COV-2 as hits for COVID-19 drug development [Internet]. Anais eletrônicos. 2023 ;[citado 2024 jun. 29 ] Available from: https://proceedings.science/sbbf-2023/papers/discovery-of-rna-dependent-rna-polymerase-complex-rdrp-inhibitors-from-sars-cov?lang=en
Trabalho de evento-resumo
Descoberta de inibidores do complexo RNA polimerase dependente de RNA (RdRp) de SARS-CoV-2 como candidatos a compostos líderes para covid-19 (2023)
Oliva, Glaucius ; Oliveira, Juliana Roberta Torini de Souza; Guido, Rafael Victorio Carvalho ; Godoy, Mariana Ortiz de
Source: Livro de Resumos. Conference titles: Semana Integrada do Instituto de Física de São Carlos - SIFSC. Unidade: IFSC
Subjects: ANTIVIRAIS, INIBIDORES DE ENZIMAS, RNA, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVA, Glaucius et al. Descoberta de inibidores do complexo RNA polimerase dependente de RNA (RdRp) de SARS-CoV-2 como candidatos a compostos líderes para covid-19. 2023, Anais.. São Carlos: Instituto de Física de São Carlos - IFSC, 2023. Disponível em: https://repositorio.usp.br/directbitstream/460a8e48-7fe2-4bf2-a026-b5453881af36/3177987.pdf. Acesso em: 29 jun. 2024.
APA
Oliva, G., Oliveira, J. R. T. de S., Guido, R. V. C., & Godoy, M. O. de. (2023). Descoberta de inibidores do complexo RNA polimerase dependente de RNA (RdRp) de SARS-CoV-2 como candidatos a compostos líderes para covid-19. In Livro de Resumos. São Carlos: Instituto de Física de São Carlos - IFSC. Recuperado de https://repositorio.usp.br/directbitstream/460a8e48-7fe2-4bf2-a026-b5453881af36/3177987.pdf
NLM
Oliva G, Oliveira JRT de S, Guido RVC, Godoy MO de. Descoberta de inibidores do complexo RNA polimerase dependente de RNA (RdRp) de SARS-CoV-2 como candidatos a compostos líderes para covid-19 [Internet]. Livro de Resumos. 2023 ;[citado 2024 jun. 29 ] Available from: https://repositorio.usp.br/directbitstream/460a8e48-7fe2-4bf2-a026-b5453881af36/3177987.pdf
Vancouver
Oliva G, Oliveira JRT de S, Guido RVC, Godoy MO de. Descoberta de inibidores do complexo RNA polimerase dependente de RNA (RdRp) de SARS-CoV-2 como candidatos a compostos líderes para covid-19 [Internet]. Livro de Resumos. 2023 ;[citado 2024 jun. 29 ] Available from: https://repositorio.usp.br/directbitstream/460a8e48-7fe2-4bf2-a026-b5453881af36/3177987.pdf
Artigo de periodico
Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon (2023)
Furtado, Nathália Dias ; Mello, Iasmim Silva de; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Oliva, Glaucius ; Canard, Bruno; Decroly, Etienne ; Bonaldo, Myrna Cristina
Source: Viruses. Unidade: IFSC
Subjects: FEBRE AMARELA, FLAVIVIRUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURTADO, Nathália Dias et al. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon. Viruses, v. 15, n. Ja 2023, p. 191-1-191-18 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15010191. Acesso em: 29 jun. 2024.
APA
Furtado, N. D., Mello, I. S. de, Godoy, A. S. de, Noske, G. D., Oliva, G., Canard, B., et al. (2023). Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon. Viruses, 15( Ja 2023), 191-1-191-18 + supplementary materials. doi:10.3390/v15010191
NLM
Furtado ND, Mello IS de, Godoy AS de, Noske GD, Oliva G, Canard B, Decroly E, Bonaldo MC. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon [Internet]. Viruses. 2023 ; 15( Ja 2023): 191-1-191-18 + supplementary materials.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/v15010191
Vancouver
Furtado ND, Mello IS de, Godoy AS de, Noske GD, Oliva G, Canard B, Decroly E, Bonaldo MC. Amino acid polymorphisms on the Brazilian strain of yellow fever virus methyltransferase are related to the host’s immune evasion mediated by type I interferon [Internet]. Viruses. 2023 ; 15( Ja 2023): 191-1-191-18 + supplementary materials.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/v15010191
Artigo de periodico
Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways (2023)
Ruiz, Uriel Enrique Aquino; Santos, Igor de Andrade; Grosche, Victória Riquena; Fernandes, Rafaela Sachetto ; Godoy, Andre Schutzer de ; Torres, Jhoan David Aguillón; Freire, Marjorie Caroline Liberato Cavalcanti ; Mesquita, Nathalya Cristina de Moraes Roso; Vega, Marco Fidel Guevara; Nicolau Junior, Nilson; Silva, Robinson Sabino da ; Mineo, Tiago Wilson Patriarca; Oliva, Glaucius ; Jardim, Ana Carolina Gomes
Source: Virus Research. Unidade: IFSC
Subjects: VÍRUS CHIKUNGUNYA, ANTIVIRAIS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUIZ, Uriel Enrique Aquino et al. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways. Virus Research, v. 324, n. Ja 2023, p. 199029-1-199029-14 + supplementary materials, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.virusres.2022.199029. Acesso em: 29 jun. 2024.
APA
Ruiz, U. E. A., Santos, I. de A., Grosche, V. R., Fernandes, R. S., Godoy, A. S. de, Torres, J. D. A., et al. (2023). Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways. Virus Research, 324( Ja 2023), 199029-1-199029-14 + supplementary materials. doi:10.1016/j.virusres.2022.199029
NLM
Ruiz UEA, Santos I de A, Grosche VR, Fernandes RS, Godoy AS de, Torres JDA, Freire MCLC, Mesquita NC de MR, Vega MFG, Nicolau Junior N, Silva RS da, Mineo TWP, Oliva G, Jardim ACG. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways [Internet]. Virus Research. 2023 ; 324( Ja 2023): 199029-1-199029-14 + supplementary materials.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.virusres.2022.199029
Vancouver
Ruiz UEA, Santos I de A, Grosche VR, Fernandes RS, Godoy AS de, Torres JDA, Freire MCLC, Mesquita NC de MR, Vega MFG, Nicolau Junior N, Silva RS da, Mineo TWP, Oliva G, Jardim ACG. Imidazonaphthyridine effects on Chikungunya virus replication: antiviral activity by dependent and independent of interferon type 1 pathways [Internet]. Virus Research. 2023 ; 324( Ja 2023): 199029-1-199029-14 + supplementary materials.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.virusres.2022.199029
Artigo de periodico
Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins (2022)
Mottin, Melina; Caesar, Lindsay K.; Brodsky, David; Mesquita, Nathalya Cristina de Moraes Roso; Oliveira, Ketllyn Irene Zagato de; Noske, Gabriela Dias; Sousa, Bruna K. P.; Ramos, Paulo R. P. S.; Jarmer, Hannah; Loh, Bonnie; Zorn, Kimberley M.; Foil, Daniel H.; Torres, Pedro M.; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Scholle, Frank; Ekins, Sean; Cech, Nadja B.; Andrade, Carolina Horta; Laster, Scott M.
Source: Bioorganic Chemistry. Unidade: IFSC
Subjects: ZIKA VÍRUS, PRODUTOS NATURAIS, FLAVIVIRIDAE, ENZIMAS, PROTEÍNAS, FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTTIN, Melina et al. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins. Bioorganic Chemistry, v. 120, p. 105649-1-105649-12 + supplementary data: 1-13, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.bioorg.2022.105649. Acesso em: 29 jun. 2024.
APA
Mottin, M., Caesar, L. K., Brodsky, D., Mesquita, N. C. de M. R., Oliveira, K. I. Z. de, Noske, G. D., et al. (2022). Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins. Bioorganic Chemistry, 120, 105649-1-105649-12 + supplementary data: 1-13. doi:10.1016/j.bioorg.2022.105649
NLM
Mottin M, Caesar LK, Brodsky D, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sousa BKP, Ramos PRPS, Jarmer H, Loh B, Zorn KM, Foil DH, Torres PM, Guido RVC, Oliva G, Scholle F, Ekins S, Cech NB, Andrade CH, Laster SM. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins [Internet]. Bioorganic Chemistry. 2022 ; 120 105649-1-105649-12 + supplementary data: 1-13.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105649
Vancouver
Mottin M, Caesar LK, Brodsky D, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sousa BKP, Ramos PRPS, Jarmer H, Loh B, Zorn KM, Foil DH, Torres PM, Guido RVC, Oliva G, Scholle F, Ekins S, Cech NB, Andrade CH, Laster SM. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins [Internet]. Bioorganic Chemistry. 2022 ; 120 105649-1-105649-12 + supplementary data: 1-13.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1016/j.bioorg.2022.105649
Artigo de periodico
Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika (2022)
Mottin, Melina ; Sousa, Bruna Katiele de Paula ; Mesquita, Nathalya Cristina de Moraes Roso; Oliveira, Ketllyn Irene Zagato de; Noske, Gabriela Dias; Sartori, Geraldo Rodrigues ; Albuquerque, Aline de Oliveira; Urbina, Fabio; Puhl, Ana C. ; Moreira Filho, José Teófilo; Souza, Guilherme Eduardo de ; Guido, Rafael Victorio Carvalho ; Muratov, Eugene ; Neves, Bruno Junior ; Silva, João Hermínio Martins da ; Clark, Alex E.; Siqueira Neto, Jair L. ; Perryman, Alexander L.; Oliva, Glaucius ; Ekins, Sean ; Andrade, Carolina Horta
Source: Journal of Chemical Information and Modeling. Unidade: IFSC
Subjects: ZIKA VÍRUS, PLANEJAMENTO DE FÁRMACOS, ANTIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOTTIN, Melina et al. Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika. Journal of Chemical Information and Modeling, v. 62, n. 24, p. 6825-6843, 2022Tradução . . Disponível em: https://doi.org/10.1021/acs.jcim.2c00596. Acesso em: 29 jun. 2024.
APA
Mottin, M., Sousa, B. K. de P., Mesquita, N. C. de M. R., Oliveira, K. I. Z. de, Noske, G. D., Sartori, G. R., et al. (2022). Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika. Journal of Chemical Information and Modeling, 62( 24), 6825-6843. doi:10.1021/acs.jcim.2c00596
NLM
Mottin M, Sousa BK de P, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sartori GR, Albuquerque A de O, Urbina F, Puhl AC, Moreira Filho JT, Souza GE de, Guido RVC, Muratov E, Neves BJ, Silva JHM da, Clark AE, Siqueira Neto JL, Perryman AL, Oliva G, Ekins S, Andrade CH. Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika [Internet]. Journal of Chemical Information and Modeling. 2022 ; 62( 24): 6825-6843.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acs.jcim.2c00596
Vancouver
Mottin M, Sousa BK de P, Mesquita NC de MR, Oliveira KIZ de, Noske GD, Sartori GR, Albuquerque A de O, Urbina F, Puhl AC, Moreira Filho JT, Souza GE de, Guido RVC, Muratov E, Neves BJ, Silva JHM da, Clark AE, Siqueira Neto JL, Perryman AL, Oliva G, Ekins S, Andrade CH. Discovery of new Zika protease and polymerase inhibitors through the open science collaboration Project OpenZika [Internet]. Journal of Chemical Information and Modeling. 2022 ; 62( 24): 6825-6843.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acs.jcim.2c00596
Artigo de periodico
Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches (2022)
Ramos, Paulo Ricardo Pimenta da Silva ; Mottin, Melina ; Lima, Caroline Sprengel ; Assis, Letícia R.; Oliveira, Ketllyn Zagato de; Mesquita, Nathalya Cristina de Moraes Roso; Cassani, Natasha Marques ; Santos, Igor Andrade ; Borba, Joyce Villa Verde Bastos ; Costa, Vinícius Alexandre Fiaia; Junior Neves, Bruno ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Jardim, Ana Carolina Gomes ; Regasini, Luis Octávio; Andrade, Carolina Horta
Source: Pharmaceuticals. Unidade: IFSC
Subjects: ZIKA VÍRUS, PLANEJAMENTO DE FÁRMACOS, QUÍMICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Paulo Ricardo Pimenta da Silva et al. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches. Pharmaceuticals, v. 15, n. 12, p. 1493-1-1493-17, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15121493. Acesso em: 29 jun. 2024.
APA
Ramos, P. R. P. da S., Mottin, M., Lima, C. S., Assis, L. R., Oliveira, K. Z. de, Mesquita, N. C. de M. R., et al. (2022). Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches. Pharmaceuticals, 15( 12), 1493-1-1493-17. doi:10.3390/ph15121493
NLM
Ramos PRP da S, Mottin M, Lima CS, Assis LR, Oliveira KZ de, Mesquita NC de MR, Cassani NM, Santos IA, Borba JVVB, Costa VAF, Junior Neves B, Guido RVC, Oliva G, Jardim ACG, Regasini LO, Andrade CH. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches [Internet]. Pharmaceuticals. 2022 ; 15( 12): 1493-1-1493-17.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/ph15121493
Vancouver
Ramos PRP da S, Mottin M, Lima CS, Assis LR, Oliveira KZ de, Mesquita NC de MR, Cassani NM, Santos IA, Borba JVVB, Costa VAF, Junior Neves B, Guido RVC, Oliva G, Jardim ACG, Regasini LO, Andrade CH. Natural compounds as non-nucleoside inhibitors of zika virus polymerase through integration of in silico and in vitro approaches [Internet]. Pharmaceuticals. 2022 ; 15( 12): 1493-1-1493-17.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/ph15121493
Trabalho de evento-resumo
Descoberta de inibidores para a protease principal (nsp5) de SARS-CoV-2: estudos estruturais e planejamento de candidatos a fármacos antivirais (2022)
Godoy, Mariana Ortiz de; Santos, Jhonathan; Noske, Gabriela Dias; Godoy, Andre Schutzer de ; Oliva, Glaucius ; Corrêa, Arlene Gonçalves ; Guido, Rafael Victorio Carvalho
Source: Livro de Resumos. Conference titles: Semana Integrada do Instituto de Física de São Carlos - SIFSC. Unidade: IFSC
Subjects: CORONAVIRUS, COVID-19, INIBIDORES DE ENZIMAS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Mariana Ortiz de et al. Descoberta de inibidores para a protease principal (nsp5) de SARS-CoV-2: estudos estruturais e planejamento de candidatos a fármacos antivirais. 2022, Anais.. São Carlos: Instituto de Física de São Carlos - IFSC, 2022. Disponível em: https://repositorio.usp.br/directbitstream/8766f4cf-5e7d-43cf-8001-16bf70141627/3121148.pdf. Acesso em: 29 jun. 2024.
APA
Godoy, M. O. de, Santos, J., Noske, G. D., Godoy, A. S. de, Oliva, G., Corrêa, A. G., & Guido, R. V. C. (2022). Descoberta de inibidores para a protease principal (nsp5) de SARS-CoV-2: estudos estruturais e planejamento de candidatos a fármacos antivirais. In Livro de Resumos. São Carlos: Instituto de Física de São Carlos - IFSC. Recuperado de https://repositorio.usp.br/directbitstream/8766f4cf-5e7d-43cf-8001-16bf70141627/3121148.pdf
NLM
Godoy MO de, Santos J, Noske GD, Godoy AS de, Oliva G, Corrêa AG, Guido RVC. Descoberta de inibidores para a protease principal (nsp5) de SARS-CoV-2: estudos estruturais e planejamento de candidatos a fármacos antivirais [Internet]. Livro de Resumos. 2022 ;[citado 2024 jun. 29 ] Available from: https://repositorio.usp.br/directbitstream/8766f4cf-5e7d-43cf-8001-16bf70141627/3121148.pdf
Vancouver
Godoy MO de, Santos J, Noske GD, Godoy AS de, Oliva G, Corrêa AG, Guido RVC. Descoberta de inibidores para a protease principal (nsp5) de SARS-CoV-2: estudos estruturais e planejamento de candidatos a fármacos antivirais [Internet]. Livro de Resumos. 2022 ;[citado 2024 jun. 29 ] Available from: https://repositorio.usp.br/directbitstream/8766f4cf-5e7d-43cf-8001-16bf70141627/3121148.pdf
Artigo de periodico
The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication (2022)
Policastro, Lucca Rocha ; Dolci, Isabela; Godoy, Andre Schutzer de ; Silva Júnior, José V. J.; Ruiz, Uriel Enrique Aquino; Santos, Igor A. ; Jardim, Ana C. G. ; Samby, Kirandeep; Burrows, Jeremy N.; Wells, Timothy N. C.; Gil, Laura Helena Vega Gonzales; Oliva, Glaucius ; Fernandes, Rafaela Sachetto
Source: Viruses. Unidade: IFSC
Subjects: FEBRE AMARELA, FLAVIVIRUS, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POLICASTRO, Lucca Rocha et al. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, v. 14, n. 7, p. 1351-1-1351-12, 2022Tradução . . Disponível em: https://doi.org/10.3390/v14071351. Acesso em: 29 jun. 2024.
APA
Policastro, L. R., Dolci, I., Godoy, A. S. de, Silva Júnior, J. V. J., Ruiz, U. E. A., Santos, I. A., et al. (2022). The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication. Viruses, 14( 7), 1351-1-1351-12. doi:10.3390/v14071351
NLM
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/v14071351
Vancouver
Policastro LR, Dolci I, Godoy AS de, Silva Júnior JVJ, Ruiz UEA, Santos IA, Jardim ACG, Samby K, Burrows JN, Wells TNC, Gil LHVG, Oliva G, Fernandes RS. The Antifungal itraconazole is a potent inhibitor of Chikungunya virus replication [Internet]. Viruses. 2022 ; 14( 7): 1351-1-1351-12.[citado 2024 jun. 29 ] Available from: https://doi.org/10.3390/v14071351
Artigo de periodico
Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate (2022)
Freire, Marjorie Caroline Liberato Cavalcanti ; Basso, Luís Guilherme Mansor; Mendes, Luis Felipe Santos ; Mesquita, Nathalya Cristina de Moraes Roso; Mottin, Melina; Fernandes, Rafaela Sachetto ; Policastro, Lucca Rocha ; Godoy, Andre Schutzer de ; Santos, Igor A. ; Ruiz, Uriel Enrique Aquino; Caruso, Icaro P.; Sousa, Bruna K. P.; Jardim, Ana C. G. ; Almeida, Fabio C. L.; Gil, Laura Helena Vega Gonzales; Andrade, Carolina H.; Oliva, Glaucius
Source: Scientific Reports. Unidades: IFSC, FFCLRP
Subjects: VÍRUS CHIKUNGUNYA, ESTRUTURA MOLECULAR (QUÍMICA TEÓRICA), QUÍMICA MÉDICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Marjorie Caroline Liberato Cavalcanti et al. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate. Scientific Reports, v. 12, p. 10601-1-10601-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-14790-x. Acesso em: 29 jun. 2024.
APA
Freire, M. C. L. C., Basso, L. G. M., Mendes, L. F. S., Mesquita, N. C. de M. R., Mottin, M., Fernandes, R. S., et al. (2022). Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate. Scientific Reports, 12, 10601-1-10601-15. doi:10.1038/s41598-022-14790-x
NLM
Freire MCLC, Basso LGM, Mendes LFS, Mesquita NC de MR, Mottin M, Fernandes RS, Policastro LR, Godoy AS de, Santos IA, Ruiz UEA, Caruso IP, Sousa BKP, Jardim ACG, Almeida FCL, Gil LHVG, Andrade CH, Oliva G. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate [Internet]. Scientific Reports. 2022 ; 12 10601-1-10601-15.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/s41598-022-14790-x
Vancouver
Freire MCLC, Basso LGM, Mendes LFS, Mesquita NC de MR, Mottin M, Fernandes RS, Policastro LR, Godoy AS de, Santos IA, Ruiz UEA, Caruso IP, Sousa BKP, Jardim ACG, Almeida FCL, Gil LHVG, Andrade CH, Oliva G. Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate [Internet]. Scientific Reports. 2022 ; 12 10601-1-10601-15.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1038/s41598-022-14790-x
Artigo de periodico
Pyronaridine protects against SARS-CoV-2 infection in mouse (2022)
Puhl, Ana C. ; Gomes, Giovanni Freitas; Damasceno, Samara; Godoy, Andre Schutzer de ; Noske, Gabriela Dias; Nakamura, Aline Minali; Oliveira, Victor Gawriljuk Ferraro; Fernandes, Rafaela Sachetto ; Monakhova, Natalia; Riabova, Olga; Lane, Thomas R.; Makarov, Vadim; Veras, Flávio Protásio ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Oliva, Glaucius ; Cunha, Fernando de Queiroz ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Ekins, Sean
Source: ACS Infectious Diseases. Unidades: FMRP, IFSC
Subjects: COVID-19, IMUNOLOGIA, AGENTES ANTIMICROBIANOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, VIRULÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PUHL, Ana C. et al. Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, v. 8, n. 6, p. 1147-1160, 2022Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.2c00091. Acesso em: 29 jun. 2024.
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Godoy, A. S. de, Noske, G. D., Nakamura, A. M., et al. (2022). Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infectious Diseases, 8( 6), 1147-1160. doi:10.1021/acsinfecdis.2c00091
NLM
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091
Vancouver
Puhl AC, Gomes GF, Damasceno S, Godoy AS de, Noske GD, Nakamura AM, Oliveira VGF, Fernandes RS, Monakhova N, Riabova O, Lane TR, Makarov V, Veras FP, Batah SS, Fabro AT, Oliva G, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Pyronaridine protects against SARS-CoV-2 infection in mouse [Internet]. ACS Infectious Diseases. 2022 ; 8( 6): 1147-1160.[citado 2024 jun. 29 ] Available from: https://doi.org/10.1021/acsinfecdis.2c00091

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Countries/Territories

Grupo de pesquisa

Funding Agencies

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration